Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Letter to Shareholders from Patriot Scientific President and CEO Rick Goerner
I think he says very clearly, settlement amounts are there:

Q3 results

I will not, in the limited context of this letter, recount all the information contained in our April 9, 2008 earnings release, which fully reflects the financial results of all transactions announced prior to the end of January 2008. PDS-related licensing activities and results were generally improved from the year earlier quarter, with a strong cash position and PTSC's public listing and share value, I am moving forward on our plan to use these resources to assess new opportunities for investment that should provide additional growth prospects for Patriot in the future.

 

FULLY REFLECTS.

Share
New Message
Please login to post a reply